Aspiro Therapeutics
PrivateLast Round
Angel
Apr 1, 2025
Total Funding Raised
$200,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aspiro Therapeutics is a biopharmaceutical company that develops small peptidomimetic therapies designed to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspiro Therapeutics Comparables
Compare Aspiro Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RaeSedo, Inc. | 84% | |
| Kinaset Therapeutics | 76% | |
| NuPeak Therapeutics, Inc. | 76% |
Aspiro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Apr 1, 2025 | ||||
| Grant | Jan 13, 2025 | ||||
| Grant | Jun 8, 2023 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 441% MoM, from 340 to 1.8K.
- Apr 1, 2025
Completed an angel funding round.
Aspiro Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aspiro Therapeutics's valuation, stock price, and market status.
Is Aspiro Therapeutics a public or private company?
Aspiro Therapeutics is a private company.
What is the current stock price of Aspiro Therapeutics?
Aspiro Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aspiro Therapeutics worth (valuation)?
Valuation information for Aspiro Therapeutics is not publicly available.
Can I buy Aspiro Therapeutics stock?
Aspiro Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aspiro Therapeutics's last funding round?
Aspiro Therapeutics's most recent funding round was Angel on April 1, 2025.
Who are the main investors in Aspiro Therapeutics?
Investor information for Aspiro Therapeutics is not publicly disclosed.
Will Aspiro Therapeutics IPO soon?
No public IPO plans have been announced for Aspiro Therapeutics.
How can I track Aspiro Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aspiro Therapeutics's secondary market activity and sign up for updates.